NCT03508258View on ClinicalTrials.gov

Study to Describe Risk of Bleeding in Patients Depending on the Different Anticoagulant Therapy They Are on for Atrial Fibrillation (AF)

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

September 1, 2017

Primary Completion Date

September 1, 2018

Study Completion Date

September 1, 2018

Conditions
Non-valvular Atrial Fibrillation
Interventions
OTHER

Non-interventional

Non-interventional

OTHER

Non-Interventional

Non-Interventional

Trial Locations (1)

20814

Local Institution, Bethesda

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT03508258 - Study to Describe Risk of Bleeding in Patients Depending on the Different Anticoagulant Therapy They Are on for Atrial Fibrillation (AF) | Biotech Hunter | Biotech Hunter